About Carrie Cunningham, MD

Dr. Carrie Cunningham is an associate professor of surgery at Harvard Medical School, section head of the Endocrine Surgery Program at Massachusetts General Hospital, and a senior scientist at the Mass General Institute for Technology Assessment. She is the Association of Endocrine Surgeons research committee chair and executive council member and the past president of the Association of Academic Surgery. Her overarching research mission has been to improve the health and well-being of patients with benign and malignant endocrine-related diseases. She is the principal investigator of an NIH/NCI R-37 (R01-type merit award) award to examine the potential impact of new diagnostic technologies and personalized management strategies in patients with thyroid cancer using mathematical disease simulation modeling and an American Cancer Society Research Scholar Award to develop a patient-reported instrument to assess thyroid-cancer specific quality of life.

Clinical Interests:

Treats:

Locations

Mass General Surgery: Surgical Oncology
55 Fruit St.
Yawkey Center for Outpatient Care
7th Floor
Boston, MA 02114
Phone: 617-724-4000

Mass General Brigham Healthcare Center
102-104 Endicott St.
Danvers, MA 01923
Phone: 978-882-6621

Medical Education

  • MD, University of Michigan Medical School
  • Residency, New York Presbyterian Hospital
  • Fellowship, Massachusetts General Hospital

American Board Certifications

  • General Surgery, American Board of Surgery

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.


Research

In addition to her clinical practice which focuses on both benign and malignant thyroid, parathyroid, and adrenal disease, Dr. Cunningham has clinical and translational research interests including prediction and decision-analytic modeling to assess the comparative effectiveness and improve the quality of care of patients with endocrine-related disorders. Her current projects involve identifying appropriate and effective diagnostic, surgical, and surveillance strategies for patients with primary hyperaldosteronism and thyroid cancer. She obtained a Master of Public Health through the Harvard School of Public Health and completed her fellowship in the Dana-Farber/Harvard Cancer Center Program in Cancer Outcomes Research Training in 2013. She continues as a senior scientist at the MGH Institute for Technology Assessment.

Publications

Reviews: Comments and Ratings

4.9out of 5(72 Ratings, 30 Comments)

January 2025

Thank you for the comoasssnd exceptional care provided in a very stressful day. Angels all of them


January 2025

Dr. Cunningham was very helpful and informative, and when she performed a minor procedure on me, she was very thoughtful and explained what she was doing as she went along, and I was extremely satisfied and felt well cared for.


October 2024

Dr Cunningham appears kind, friendly, smart and efficient. All good! My impression is that she is an outstanding physician and that I am fortunate that she is involved in my care.


October 2024

well prepared, thoughtful, knowledgeable, thorough. asked all the questions needed to relay information necessary and answered all questions asked. Discussed unknowns. Overall, instilled confidence in understanding what needed to be done.


October 2024

She was clear about the procedure, friendly and warm.


September 2024

She was very direct, to the point, gave me the right diagnosis abdcwascwillingbtonpergirm my surgery . Carrie seems professional and willing to listen to all my questions . I'm happy she'll be my surgeon and looking forward to having over .


September 2024

She was friendly and efficient. Like her very much!


September 2024

Excellent doctor


September 2024

She Was Excellent


September 2024

Dr. Cunningham is warm, intelligent obviously, and was clear in her response.

View More
Ratings and Comments Powered by NRC Health